SCCA Awards Nursing Scholarships

Last week SCCA awarded three junior nursing students with the first ever Future of Oncology Nursing Scholarship. SCCA is striving to create a center of excellence in oncology nursing, and this new scholarship program is intended to inspire local nursing students to pursue a career in oncology.

“We have a wonderful team of specialized oncology nurses, and we want to mentor young nurses into this kind of practice,” said Kathleen Shannon Dorcy, who is the Director of Clinical/Nursing Research, Education, and Practice at SCCA. “We are delighted that Seattle University, Seattle Pacific, and the University of Washington nursing programs all participated, and that we’ve selected three promising, enthusiastic students for the inaugural scholarship.”

nursing-scholars-2

From left to right: Stephanie Stoll; Kathleen Shannon Dorcy, Director of Clinical/Nursing Research Education and Practice; Corinne Valencia; Angelique Richard, Chief Nurse Executive and Vice President of Clinical Operations; and Lyndsey Kellar.

This year’s winners are Stephanie Stoll from Seattle University,  Corinne Valencia from Seattle Pacific, and Lyndsey Kellar from the University of Washington. They were selected from a pool of more than 20 applicants by a committee of nurses here at SCCA. To qualify, each student needed at least a 3.2 grade point average and a faculty recommendation. In addition, each had to complete a 250-word essay about why they would consider a career in oncology nursing. The scholarship is for $3,000. Congratulations to Stephanie, Corinne, and Lyndsey!

    Posted in General | Leave a comment

    SCCA Clinical Trial Openings

    Clinical TrialsListed below are clinical trials that have opened at SCCA in the last several weeks. These trials are looking at new treatments for patients with melanoma, clear cell renal cell carcinoma, squamous cell head and neck cancer, patients 65 years or older with acute myelogenous leukemia, patients with myelodysplastic syndrome or chronic myelomonocytic leukemia, and patients with non-small cell lung cancer.  Check out our website to learn about the more than 200 ongoing clinical trials at SCCA, and follow us on Twitter at @SCCA_Trials  for information about recently opened trials.

    PF-04518600 for Selected Solid Tumors
    A Phase 1, Open-Label, Dose Escalation Study of Pf-04518600 in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma (Hcc), Melanoma, Clear Cell Renal Cell Carcinoma (Rcc), or Squamous Cell Head and Neck Cancer (Scchn)

    ABT-199 + Decitabine or Azacitidine for Acute Myelogenous Leukemia (20141655)
    A Phase 1b Study of ABT-199 (GDC-0199) in Combination with Azacitidine or Decitabine in Treatment Naïve Subjects with Acute Myelogenous Leukemia Who Are = 65 Years of Age and Who Are Not Eligible for Standard Induction Therapy

    Azacitidine w/wo Birinapant for Higher Risk MDS or CML (9185)
    Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Azacitidine with or without Birinapant with a Single Arm Open-Label Run-In Phase in Subjects with Higher Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

    PF-06747775 for Advanced EGFRm Non-Small Cell Lung Cancer (20150645)
    Phase 1/2 Open-Label Study of PF-06747775 (Epidermal Growth Factor Receptor T790M Inhibitor) in Patients with Advanced Epidermal Growth Factor Receptor Mutant (DEL 19 OR L858R +/- T790M) Non-Small Cell Lung Cancer

      Posted in Clinical Trials | Leave a comment

      SCCA Volunteer Spotlight: Fred Speaks

      On Thursday afternoons the smiles grow a little wider when Fred Speaks walks through the door at Shine. Fred has been fitting wigs and cutting hair for patients and caregivers at SCCA for the last two years. He’s been a hair designer for over 40 years in places such as Chicago, Houston, and Seattle. His past clients include James Farentino, Michele Lee, Nancy Marshall, Eva Gabor, Sarah Miles, and Zsa Zsa Gabor. He’s even been called to style the hair of Her Royal Highness, Princess Margaret of Great Britain.

      FredSpeaks-350vBut on Thursdays, Fred volunteers at SCCA. “I usually get five to 10 folks,” he says. “Sometimes for a head shave, sometimes for a bang or beard trim. And sometimes people sneak other people in,” he adds impishly.

      Hair loss is a common side effect for many cancer patients, especially those undergoing chemotherapy. Fred explains that for anyone, but especially for women, it’s traumatic to lose all your hair. “My job is to help them over the hurdle of being bald,” he says.

      Shine offers wigs in a variety of sizes, colors, and styles–from petite to large; blond to black; straight to curly and most everything in-between. And what’s not in stock can be ordered.

      Fred’s approach to hair styling is definitely old school. Unlike most hairdressers, he still uses a razor to cut. And when it comes to wigs, he says most hairdressers today have no idea what to do. While wigs used to be quite common and fashionable–a woman might have worn a wig two or three times a week— these days wigs are associated more with being bald and sick than about making a fashion statement.

      FredSpeak-cutting-hThe wigs offered at Shine are all synthetic, so what you see is what you get. “You can’t add curls to a straight synthetic wig,” he says. But you can make it look less like a wig and more like your own hair with the help of someone like Fred.

      In addition to wig fitting, SCCA offers complimentary wig trimming and head shaves. Please call (206) 288-7560 for more information and to schedule an appointment.

        Posted in SCCA Volunteers | Leave a comment

        Glassybaby Sale at SCCA

        glassybaby-goodnessIf you’re looking for Mother’s Day gift ideas, stop by the first floor of the SCCA Clinic this Friday, May 8, between 10 a.m. and 4 p.m., where local company glassybaby is hosting a road show in honor of Nurse’s Week. Not only do glassybaby’s hand-blown candle holders make great Mother’s Day gifts, 10 percent of the proceeds from the event will be donated to the white light fund, which supports the SCCA Future of Oncology Nursing Scholarship.

        If you’re not able to make it to the event, you can still participate by shopping online from May 8 through May 14. Enter the giving code ‘scca’ when checking out, and 10 percent of your online purchase will support the Future of Oncology Nursing Scholarship.

          Posted in General | Leave a comment

          SCCA Clinical Trial Openings

          stemcellsListed below are clinical trials that have opened at SCCA in the last several weeks. These trials are looking at new treatments for patients with metastatic prostate cancer, pediatric patients undergoing a transplant, patients with non-small cell lung cancer or advanced soft tissue sarcoma, and spousal caregivers of patients with stage III/IV ovarian cancer. Check out our website to learn about the more than 200 ongoing clinical trials at SCCA. And follow us on Twitter at @SCCA_Trials  for information about recently opened trials.

          Radium-223 Dichloride + Standard Treatment for Metastatic Prostate Cancer (20141419)
          A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Radium-223 Dichloride in Combination With Abiraterone Acetate and Prednisone/Prednisolone in the Treatment of Asymptomatic or Mildly Symptomatic Chemotherapy-Naïve Subjects With Bone Predominant Metastatic Castration-Resistant Prostate Cancer (CRPC)

          Pamidronate Post Transplant for Pediatric Patients (9223)
          Prevention of Bone Loss after Pediatric Hematopoietic Cell Transplantation

          MK-3475 (SCH900475)+ Chemotherapy or Immunotherapy for Non-Small Cell Lung Carcinoma (20141233)
          A Phase I/II Study of MK-3475 (SCH900475) in Combination with Chemotherapy or Immunotherapy in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Carcinoma

          Olaratumab +Doxorubicin for Advanced Soft Tissue Sarcoma (UW14068)
          An Open-Label Study to Evaluate the Pharmacokinetics of Doxorubicin Following the Concomitant Intravenous Administration of Olaratumab (IMC-3G3) to Patients with Advanced Soft Tissue Sarcoma

          Taking Care of Her (9306)
          A Pilot Feasibility Study: Taking Care of Her

            Posted in Clinical Trials | Leave a comment
            • This-One-Thing-260